Baby boy was treated with the first personalized gene-editing drug | MIT Technology Review

The one-off treatment highlights the promise of a new type of gene editing and the challenges of using it to treat extremely rare genetic diseases.

This baby boy was treated with the first personalized gene-editing drug | MIT Technology Review Skip to Content Doctors say they constructed a bespoke gene-editing treatment in less than seven months and used it to treat a baby with a deadly metabolic condition. The rapid-fire attempt to rewrite the child’s DNA marks the first time gene editing has been tailored to treat a single individual, according to a report published in the New England Journal of Medicine . The baby who was treated, Kyle “KJ” Muldoon Jr., suffers from a rare metabolic condition caused by a particularly unusual gene missp

related reading

• Significantly Enhancing Adult Intelligence With Gene Editing May Be Possible — LessWronglesswrong.com
• Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
• FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease | Scientific Americanscientificamerican.com
• Curative gene therapies for rare diseases - PMCncbi.nlm.nih.gov
• UK first to approve CRISPR treatment for diseases: what you need to knownature.com
• Announcing Preventive — Preventivepreventive.bio
• George Church: The Future Without Limit | Innovators | National Geographicnationalgeographic.com
• Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
• FDA Launches Framework for Accelerating Development of Individualized Therapies for Ultra-Rare Diseases | FDAfda.gov
• CRISPR Gene Therapy: Applications, Limitations, and Implications for the Futurencbi.nlm.nih.gov
• The Practical Guide to Superbabies — LessWronglesswrong.com
• Large NIH Grant Supports CRISPR-based Gene Therapy Development for Brain Diseases | Yale School of Medicinemedicine.yale.edu